pipette
ESEspañol

Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer

Clemens Hinterleitner, Valentin J.A. Barthet, Hailey V. Goldberg, Kristen C. Vogt, Ana Marie Perea, Logan R. Hillger, Stephen B. Ruiz, Domhnall McHugh, Yu-Jui Ho, Almudena Chaves Perez, Maria Skamagki, Sara Flowers, Hannah C. Styers, Natasha Rekhtman, Xueqian Zhuang, Gabriel Dessotti Barretto, Xiang Li, Jadae T. Watson, Wei Luan, Janelle Simon, Tuomas Tammela, Rui Gardner, Charles M. Rudin, Paul Bernard Romesser, Matthew Joseph Bott, Aveline A. Filliol, Daniel A. Heller, Scott W. Lowe

Peer-reviewed journalBold claims, read criticallyReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
These findings establish SMNPs as a generalizable strategy to target pathogenic senescent cell subsets across fibrosis and cancer.

Appeared: Saturday, September 26. Science. Peer-reviewed journal.

DOI: 10.1126/science.aeg4791